559 related articles for article (PubMed ID: 15615075)
1. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
[TBL] [Abstract][Full Text] [Related]
2. Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats.
Chen H; Tian X; Liu X; Setterberg RB; Li M; Jee WS
Calcif Tissue Int; 2008 Feb; 82(2):127-36. PubMed ID: 18175034
[TBL] [Abstract][Full Text] [Related]
3. Greater efficacy of alfacalcidol in the red than in the yellow marrow skeletal sites in adult female rats.
Tian XY; Liu XQ; Chen HY; Setterberg RB; Li M; Jee WS
J Musculoskelet Neuronal Interact; 2008; 8(3):257-66. PubMed ID: 18799859
[TBL] [Abstract][Full Text] [Related]
4. Alfacalcidol increases cancellous bone in low turnover, fatty marrow sites in aged, orchidectomized rats.
Tian XY; Chen HY; Setterberg RB; Li M; Jee WS
J Musculoskelet Neuronal Interact; 2009; 9(3):138-46. PubMed ID: 19724148
[TBL] [Abstract][Full Text] [Related]
5. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
7. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
Iwamoto J; Yeh JK; Takeda T
J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
[TBL] [Abstract][Full Text] [Related]
9. Alfacalcidol restores cancellous bone in ovariectomized rats.
Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
[TBL] [Abstract][Full Text] [Related]
10. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):191-7. PubMed ID: 17874822
[TBL] [Abstract][Full Text] [Related]
11. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
12. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
13. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
Xia W; Meng X; Xing X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):702-5. PubMed ID: 11798840
[TBL] [Abstract][Full Text] [Related]
14. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
15. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen.
Shiraishi A; Takeda S; Masaki T; Higuchi Y; Uchiyama Y; Kubodera N; Sato K; Ikeda K; Nakamura T; Matsumoto T; Ogata E
J Bone Miner Res; 2000 Apr; 15(4):770-9. PubMed ID: 10780869
[TBL] [Abstract][Full Text] [Related]
16. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
[TBL] [Abstract][Full Text] [Related]
17. Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats.
Tanaka Y; Nakamura T; Nishida S; Suzuki K; Takeda S; Sato K; Nishii Y
J Bone Miner Res; 1996 Mar; 11(3):325-36. PubMed ID: 8852943
[TBL] [Abstract][Full Text] [Related]
18. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
20. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
